<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="http://www.theraclion.com/xml/rss.xsl" type="text/xsl" media="screen"?>
<?xml-stylesheet href="http://www.theraclion.com/xml/rss.css" type="text/css" media="screen"?>
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"  xmlns:media="http://search.yahoo.com/mrss/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:georss="http://www.georss.org/georss" xmlns:photo="http://www.pheed.com/pheed/">
 <channel>
  <title>Theraclion, the sound therapy</title>
  <description><![CDATA[Theraclion, a leading specialist for the HIFU, non-invasive treatment of head and neck pathologies.]]></description>
  <link>http://www.theraclion.com/</link>
  <language>us</language>
  <dc:date>2012-02-07T06:06:25+01:00</dc:date>
  <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="alternate" href="http://www.theraclion.com/xml/atom.xml" type="text/xml" />
  <item>
   <guid isPermaLink="false">tag:www.theraclion.com,2012:rss-3703546</guid>
   <title>Fibroadenoma_bg</title>
   <pubDate>Mon, 23 Jan 2012 12:09:00 +0100</pubDate>
   <dc:language>us</dc:language>
   <dc:creator>Valérie Pujol</dc:creator>
   <dc:subject><![CDATA[Fibroadénome]]></dc:subject>
   <description>
   <![CDATA[
   Имате добро- качествен тумор на гърдата?     <div style="position:relative; float:left; padding-right: 1ex;">
      <img src="http://www.theraclion.com/photo/art/default/3703546-5477353.jpg" alt="Fibroadenoma_bg" title="Fibroadenoma_bg" />
     </div>
     <div>
       <br />  <strong>Вие сте навършили 18 г.</strong>, случайно сте напипали „бучка” в гърдата, която вашият мамолог определя като доброкачествен тумор и обсъжда с вас хирургично лечение. <br />   <br />  Ние ви предлагаме да участвате в програма за клинично проучване на приложението на нов, неинвазивен метод за лечение с ултразвук. Лечението и последващите консултации са безплатни за пациентките. <br />   <br />  <strong>Ако имате интерес, можете да се обърнете към доц. Р. Ковачева, Майчин дом, ет. 13, тел. 02/895 62 21, понеделник до петък, 9 – 13 ч.</strong>
     </div>
     <br style="clear:both;"/>
   ]]>
   </description>
   <photo:imgsrc>http://www.theraclion.com/photo/art/imagette/3703546-5477353.jpg</photo:imgsrc>
   <link>http://www.theraclion.com/Fibroadenomabg_a128.html</link>
  </item>

  <item>
   <guid isPermaLink="false">tag:www.theraclion.com,2012:rss-3618582</guid>
   <title>validation Pub Flash</title>
   <pubDate>Thu, 05 Jan 2012 22:40:00 +0100</pubDate>
   <dc:language>us</dc:language>
   <dc:creator>Valérie Pujol</dc:creator>
   <dc:subject><![CDATA[Test pub]]></dc:subject>
   <description>
   <![CDATA[
        <div>
      
     </div>
     <br style="clear:both;"/>
   ]]>
   </description>
   <link>http://www.theraclion.com/validation-Pub-Flash_a127.html</link>
  </item>

  <item>
   <guid isPermaLink="false">tag:www.theraclion.com,2012:rss-3492430</guid>
   <title>Fibroadénome</title>
   <pubDate>Wed, 30 Nov 2011 15:54:00 +0100</pubDate>
   <dc:language>us</dc:language>
   <dc:creator>Valérie Pujol</dc:creator>
   <dc:subject><![CDATA[Fibroadénome]]></dc:subject>
   <description>
   <![CDATA[
        <div>
      <div>  	<strong>Vous avez une tumeur bénigne du sein ? Ceci peut vous intéresser. <br />  	 <br />  	Etude clinique pour le traitement de tumeurs bénignes par ultrasons :</strong> <br />  	 <br />  	Vous avez plus de 18 ans, une masse palpable&nbsp;du sein avec un diagnostic de tumeur&nbsp;bénigne et votre médecin a discuté avec vous d’une possible intervention chirurgicale.&nbsp;Nous vous proposons de participer à une&nbsp;étude clinique qui évalue un nouveau traitement&nbsp;non chirurgical par ultrasons. Le traitement&nbsp;et les consultations de suivi seront&nbsp;complètement pris en charge. <br />  	&nbsp;</div>  
     </div>
     <br style="clear:both;"/>
     <div style="position:relative; float:right; padding-left: 1ex;">
      <img src="http://www.theraclion.com/photo/art/default/3492430-5570567.jpg" alt="Fibroadénome" title="Fibroadénome" />
     </div>
     <div>
      <div>  	<strong>Si vous êtes intéressée adressez-vous :</strong> <br />  	 <br />  	<span style="color: rgb(102, 102, 102);">● </span>au service de gynécologie de<strong> l’Hôpital&nbsp;Américain de Paris <br />  	 <br />  	01 46 41 26 57 ou 27 37&nbsp;</strong>( de 9h à 18h, du lundi au vendredi ) <br />  	 <br />  	ou <br />  	&nbsp; <br />  	<span style="color: rgb(102, 102, 102);">● </span>au service de gynécologie de<strong> l'hôpital Jeanne de Flandre à Lille </strong></div>   <br />  <strong>03 20 44 67 57 </strong>( de 8h à 12h, et de 13h à 16h30, du lundi au vendredi ) <br />  
     </div>
     <br style="clear:both;"/>
     <div style="position:relative; float:left; padding-right: 1ex;">
      <img src="http://www.theraclion.com/photo/art/default/3492430-5570581.jpg" alt="Fibroadénome" title="Fibroadénome" />
     </div>
     <div>
       <br />  <strong>Rejoignez-nous sur</strong>&nbsp;<a class="link" href="http://www.facebook.com/pages/Theraclion/303792825050" onclick="window.open(this.href,'_blank');return false;">Facebook</a>  &nbsp;!&nbsp; <br />   <br />  
     </div>
     <br style="clear:both;"/>
     <div>
       <br />  <strong>Le fibroadénome du sein est la tumeur bénigne du sein la plus répandue. 10% des femmes développeront un fibroadénome durant leur vie.</strong> <br />   <br />  Aux Etats-Unis, ils représentent la moitié des 1,6 millions de biopsies réalisées chaque année. <br />   <br />  
     </div>
     <br style="clear:both;"/>
     <div style="position:relative; float:left; padding-right: 1ex;">
      <img src="http://www.theraclion.com/photo/art/default/3492430-5570666.jpg" alt="Fibroadénome" title="Fibroadénome" />
     </div>
     <div>
      En France, le nombre de fibroadénomes détectés annuellement est estimé à plusieurs dizaines de milliers. Cette pathologie est observée à tout âge mais concerne très majoritairement les femmes de moins de 30 ans. La présence d’un fibroadénome est généralement détectée à la palpation. Toutefois, le fibroadénome peut s’avérer asymptomatique et&nbsp; être découvert&nbsp; à l’occasion d’une mammographie ou d’une échographie. Tout nodule détecté dans le sein fait l’objet d’une cytoponction ou d’une microbiopsie. Si l’analyse révèle un fibroadénome, le praticien et sa patiente décident ensemble soit d’un suivi régulier de son évolution, soit de son ablation, particulièrement s’il gêne la patiente, s’il grossit ou s’il est générateur d’anxiété. <br />   <br />  La bénignité du fibroadénome pose, tant à la patiente qu’au praticien, la question de la nécessité du recours à la chirurgie. <br />   <br />   <br />  Les ultrasons focalisés de haute intensité (HIFU) seraient la réponse appropriée à cette question. <br />   <br />  <strong>Pour plus d’informations sur la solution Theraclion pour les fibroadénomes du sein,</strong> <a class="link" href="http://www.theraclion.com/docs/Press/cp_fibroadenomedusein_29112011.pdf" onclick="window.open(this.href,'_blank');return false;"><span class="link">cliquez-ici</span></a>.
     </div>
     <br style="clear:both;"/>
   ]]>
   </description>
   <photo:imgsrc>http://www.theraclion.com/photo/art/imagette/3492430-5570567.jpg</photo:imgsrc>
   <link>http://www.theraclion.com/Fibroadenome_a125.html</link>
  </item>

  <item>
   <guid isPermaLink="false">tag:www.theraclion.com,2012:rss-3492372</guid>
   <title>Fibroadenoma</title>
   <pubDate>Wed, 30 Nov 2011 15:43:00 +0100</pubDate>
   <dc:language>us</dc:language>
   <dc:creator>Valérie Pujol</dc:creator>
   <dc:subject><![CDATA[Fibroadenoma]]></dc:subject>
   <description>
   <![CDATA[
        <div>
      Breast fibroadenoma is the most common benign breast&nbsp; tumor. 10% of women will develop a fibroadenoma at some point in their lifetime. <br />   <br />  In the United States,&nbsp; fibroadenomas account for around&nbsp; half of the 1.6 million breast biopsies performed each year. <br />   <br />  In France, several tens of thousands of fibroadenomas are detected each year. This pathology can be observed at any age but mainly concerns women under 30. The fibroadenoma is generally detected by palpation. However, the fibroadenoma can be&nbsp; asymptomatic and may&nbsp; only be detected after a mammography or an ultrasound examination.&nbsp; Detection of a nodule&nbsp; in the breast will prompt&nbsp; cytopuncture&nbsp; or a microbiopsy. If the analysis reveals a fibroadenoma, the physician and the patient will decide on the best course of action: regular monitoring or (if the fibroadenoma is bothersome, growing in size or causing anxiety) ablation. The benign nature of the fibroadenoma means that both the patient and physician may consider that surgery is not an appropriate option. The HIFU may be a well-matched response to this problem. <br />   <br />  For more information about Theraclion’s answer to breast fibroadenomas, please <a class="link" href="http://www.theraclion.com/docs/Press/pr_breastfibro_11292011.pdf" onclick="window.open(this.href,'_blank');return false;"><span class="link">click-here</span></a>. <br />   <br />  
     </div>
     <br style="clear:both;"/>
   ]]>
   </description>
   <link>http://www.theraclion.com/Fibroadenoma_a124.html</link>
  </item>

  <item>
   <guid isPermaLink="false">tag:www.theraclion.com,2012:rss-2874894</guid>
   <title>Plan du site</title>
   <pubDate>Fri, 08 Apr 2011 10:41:00 +0200</pubDate>
   <dc:language>us</dc:language>
   <dc:creator>Valérie Pujol</dc:creator>
   <dc:subject><![CDATA[Plan du site]]></dc:subject>
   <description>
   <![CDATA[
        <div>
      ●<span style="font-weight: bold;"> </span><a class="link" href="http://www.theraclion.com"><span style="font-weight: bold;">Version anglaise</span></a>                                          <br />                           <br />● <a class="link"  href="http://www.theraclion.com/AccueilFR_r52.html">Accueil version française</a>                            <br />                                                                     <br />●<span style="font-weight: bold;"> </span><span style="font-weight: bold;">Notre société</span>                      <br />&nbsp;&nbsp;&nbsp;&nbsp; - <a class="link"  href="http://www.theraclion.com/Presentation_r55.html">Présentation</a>                          <br />&nbsp;&nbsp;&nbsp;&nbsp; - <a class="link"  href="http://www.theraclion.com/Equipe-et-Direction_r56.html">Equipe et direction</a>                                         <br />&nbsp;&nbsp;&nbsp;&nbsp; - <a class="link"  href="http://www.theraclion.com/Conseillers_r57.html">Conseillers</a>                        <br />&nbsp;&nbsp;&nbsp;&nbsp; - <a class="link"  href="http://www.theraclion.com/Carrieres_r58.html">Carrières</a>                                                                    <br />                                                                     <br />●<span style="font-weight: bold;"> </span><span style="font-weight: bold;">Nos produits</span>                     <br />&nbsp;&nbsp;&nbsp;&nbsp;<span style="font-weight: bold;"> </span>- <a class="link"  href="http://www.theraclion.com/TH-One_r60.html">TH-One</a>                    <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a class="link"  href="http://www.theraclion.com/Information-produit_r61.html">Information produit</a>                   <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a class="link"  href="http://www.theraclion.com/Securite_r62.html">Sécurité</a>                                                                    <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a class="link"  href="http://www.theraclion.com/Qualite_r63.html">Qualité</a>                  <br />&nbsp;&nbsp;&nbsp;&nbsp; - <a class="link"  href="http://www.theraclion.com/HIFU_r64.html">HIFU</a>                  <br />&nbsp;&nbsp;&nbsp;&nbsp; - <a class="link"  href="http://www.theraclion.com/Procedure-clinique_r65.html">Procédure clinique</a>                                                                      <br />                                  <br />●<span style="font-weight: bold;"> </span><span style="font-weight: bold;">Médecins</span>                 <br />&nbsp;&nbsp;&nbsp;&nbsp;<span style="font-weight: bold;"> </span>- <a class="link"  href="http://www.theraclion.com/TH-One_r67.html">TH-One</a>                 <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a class="link"  href="http://www.theraclion.com/Information-produit_r68.html">Information produit</a>                                                                    <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a class="link"  href="http://www.theraclion.com/Securite_r69.html">Sécurité</a>                                  <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a class="link"  href="http://www.theraclion.com/Qualite_r70.html">Qualité</a>               <br />&nbsp;&nbsp;&nbsp;&nbsp; - <a class="link"  href="http://www.theraclion.com/HIFU_r71.html">HIFU</a>              <br />&nbsp;&nbsp;&nbsp;&nbsp; - <a class="link"  href="http://www.theraclion.com/Efficacite-clinique_r72.html">Efficacité clinique</a>             <br />&nbsp; &nbsp;&nbsp; - <a class="link"  href="http://www.theraclion.com/Temoignages_r73.html">Témoignages</a>            <br />&nbsp;&nbsp;&nbsp;&nbsp; - <a class="link"  href="http://www.theraclion.com/Publications_r74.html">Publications</a>                                  <br />                                                                       <br />●<span style="font-weight: bold;"> </span><span style="font-weight: bold;">Patients </span>                                                                    <br />&nbsp;&nbsp;&nbsp;&nbsp; - <a class="link"  href="http://www.theraclion.com/Thyroide_r76.html">Thyroïde</a>           <br />&nbsp;&nbsp;&nbsp;&nbsp; - <a class="link"  href="http://www.theraclion.com/Parathyroide_r77.html">Parathyroïde</a>          <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <a class="link"  href="http://www.theraclion.com/Anatomie-et-Physiologie_r78.html">Anatomie et Physiologie</a>         <br />&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; <a class="link"  href="http://www.theraclion.com/Pathologies-des-glandes-parathyroides_r79.html">Pathologies des glandes parathyroïdes</a>                                      <br />&nbsp;&nbsp;&nbsp;&nbsp; - <a class="link"  href="http://www.theraclion.com/Questions-frequentes-FAQ_r80.html">Questions fréquentes</a>       <br />&nbsp;&nbsp;&nbsp;&nbsp; - <a class="link"  href="http://www.theraclion.com/Temoignages_r81.html">Témoignages</a>      <br />&nbsp;&nbsp; &nbsp; - <a class="link"  href="http://www.theraclion.com/Publications_r82.html">Publications</a>                                      <br />&nbsp;&nbsp;&nbsp;&nbsp; - <a class="link"  href="http://www.theraclion.com/Liens-utiles_r83.html">Liens utiles</a>                                                                  <br />                                                                     <br />●<span style="font-weight: bold;"> </span><span style="font-weight: bold;">Actualité &amp; Médias</span>    <br />&nbsp;&nbsp;&nbsp;&nbsp; - <a class="link"  href="http://www.theraclion.com/Information-concernant-la-societe_r85.html">Information concernant la société</a>   <br />&nbsp;&nbsp;&nbsp;&nbsp; - <a class="link"  href="http://www.theraclion.com/Lu-dans-la-presse_r87.html">Lu dans la presse</a>                                                                  <br />                                                                     <br />●<span style="font-weight: bold;"> </span><a class="link" href="http://www.theraclion.com/Contact_r88.html"><span style="font-weight: bold;">Contact</span></a>                                              <br />                                                  <br />                                                                     <br />
     </div>
     <br style="clear:both;"/>
   ]]>
   </description>
   <link>http://www.theraclion.com/Plan-du-site_a123.html</link>
  </item>

 </channel>
</rss>

